{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:15:34Z","timestamp":1792826134965,"version":"4.5.0"},"reference-count":106,"publisher":"SAGE Publications","issue":"2_suppl","license":[{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100017751","name":"NIHR BioResource","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017751","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Susan and Charles Berghoff Foundation"},{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["848002"],"award-info":[{"award-number":["848002"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["MA- RxRD-0000003242-2018"],"award-info":[{"award-number":["MA- RxRD-0000003242-2018"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>Cognitive impairment is a common non-motor symptom in people with Parkinson's disease (PD) and is associated to poor clinical outcomes. Currently, rivastigmine is the only approved medication for PD dementia, and there are no treatments available for people with PD and mild cognitive impairment. To advance the pharmacological management of cognitive impairment in PD, it is essential to optimize clinical trial design. This includes refining cognitive outcome measures, ensuring longer study durations, and incorporating PD-specific cognitive assessments. Biomarkers offer valuable opportunities for screening, stratification, enrichment, and monitoring in trials, increasing the likelihood of detecting treatment effects. Additionally, adopting patient-centered approaches that prioritize inclusivity can enhance trial validity and address the current lack of diversity in PD studies. Digital cognitive assessments offer a promising tool for improving participation and enabling longitudinal monitoring, especially in underrepresented and mobility-challenged populations. By tackling these challenges, this review outlines strategies for advancing the pharmacological management of cognitive impairment in PD. It emphasizes the need for precise, inclusive, and biomarker-driven trials to accelerate drug development.<\/jats:p>","DOI":"10.1177\/1877718x251315645","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T01:12:17Z","timestamp":1738545137000},"page":"81-91","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["How to advance the pharmacological management of cognitive impairment in Parkinson's disease"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7636-9758","authenticated-orcid":false,"given":"Carla","family":"Abdelnour","sequence":"first","affiliation":[{"name":"Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9815-3616","authenticated-orcid":false,"given":"Lucy L","family":"Gibson","sequence":"additional","affiliation":[{"name":"Old Age Psychiatry Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6249-2803","authenticated-orcid":false,"given":"Lucia","family":"Batzu","sequence":"additional","affiliation":[{"name":"Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK"},{"name":"Parkinson's Foundation Centre of Excellence, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6314-216X","authenticated-orcid":false,"given":"Dag","family":"Aarsland","sequence":"additional","affiliation":[{"name":"Old Age Psychiatry Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK"},{"name":"Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,2,2]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.69.3.308"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00280-3"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29918"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27135"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pbr.2022.01.003"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.6.730"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-305277"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/08919887231195219"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006576"},{"key":"e_1_3_3_11_2","first-page":"1362053","article-title":"Coping with cognitive impairment in people with Parkinson's disease and their carers: a qualitative study","volume":"2018","author":"Lawson RA","year":"2018","unstructured":"Lawson RA, Collerton D, Taylor JP, et al. Coping with cognitive impairment in people with Parkinson's disease and their carers: a qualitative study. Parkinsons Dis 2018; 2018: 1362053.","journal-title":"Parkinsons Dis"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4623"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/0891988712464823"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-023-00918-8"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21507"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24893"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003634"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(02)00065-9"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.10.1916"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00405-2"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaa090"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13347"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-015-1919-7"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10639"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2011.08.014"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27372"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041470"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-307659"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21077"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20700"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70194-0"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4109"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105385"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26236"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26617"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26102"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28198"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28879"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25864"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202867"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28582"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9121881"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-240272"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2014.02.012"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14698"},{"key":"e_1_3_3_46_2","first-page":"1234","article-title":"Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies","volume":"90","author":"Smith C","year":"2019","unstructured":"Smith C, Malek N, Grosset K, et al. Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry 2019; 90: 1234\u20131243.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.02.023"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.4222"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.27003"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0333-5"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13109"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02449-7"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14250"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-023-02631-8"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01103-7"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.841"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71922-1"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101379"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00404-0"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.10.007"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.05.020"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207755"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-213113"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-179901"},{"key":"e_1_3_3_65_2","volume-title":". Crossing the Quality Chasm: A New Health System for the 21st Century","author":"Institute of Medicine (US) Committee on Quality of Health Care in America","year":"2001","unstructured":"Institute of Medicine (US) Committee on Quality of Health Care in America. . Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academies Press (US), 2001."},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71555-4"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.14089"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30064-8"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.02.012"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00716-z"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000842"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28182"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212948"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27233"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1764204"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-230051"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22007"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000091864.39702.1C"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.08.008"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209609"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13919"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1630.12288"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2023.1325215"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27906"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.3390\/s23115160"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-020-0401-2"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1363513"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1177\/1073191116643164"},{"key":"e_1_3_3_90_2","article-title":"Current advances in digital cognitive assessment for preclinical Alzheimer's disease","volume":"13","author":"Ohman F","year":"2021","unstructured":"Ohman F, Hassenstab J, Berron D, et al. Current advances in digital cognitive assessment for preclinical Alzheimer's disease. Alzheimers Dement (Amst) 2021; 13: e12217.","journal-title":"Alzheimers Dement (Amst)"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1093\/geroni\/igy038"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-00974-9"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1355617721000503"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2022.880055"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.1017\/S135561772200042X"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2022.933265"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9414"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1080\/13854046.2016.1190405"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105908"},{"key":"e_1_3_3_100_2","article-title":"Can physical exercise be considered as a promising enhancer of global cognition in people with Parkinson's disease? Results of a systematic review and meta-analysis","volume":"14","author":"Folkerts AK","year":"2024","unstructured":"Folkerts AK, Ernst M, Gollan R, et al. Can physical exercise be considered as a promising enhancer of global cognition in people with Parkinson's disease? Results of a systematic review and meta-analysis. J Parkinsons Dis 2024; 14: S115\u2013S133.","journal-title":"J Parkinsons Dis"},{"key":"e_1_3_3_101_2","article-title":"Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease","volume":"2","author":"Orgeta V","year":"2020","unstructured":"Orgeta V, McDonald KR, Poliakoff E, et al. Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease. Cochrane Database Syst Rev 2020; 2: CD011961.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05772-4"},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-024-07808-x"},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.1177\/1545968316680489"},{"key":"e_1_3_3_105_2","article-title":"Dementia with Lewy bodies research consortia: a global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group","volume":"13","author":"D'Antonio F","year":"2021","unstructured":"D'Antonio F, Kane JPM, Ibanez A, et al. Dementia with Lewy bodies research consortia: a global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group. Alzheimers Dement (Amst) 2021; 13: e12235.","journal-title":"Alzheimers Dement (Amst)"},{"key":"e_1_3_3_106_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00533-w"},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29126"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X251315645","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X251315645","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X251315645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T23:21:12Z","timestamp":1783207272000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X251315645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,2]]},"references-count":106,"journal-issue":{"issue":"2_suppl","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1177\/1877718X251315645"],"URL":"https:\/\/doi.org\/10.1177\/1877718x251315645","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,2]]}}}